Dr. Kenneth Cusi is a Professor of Medicine and Chief of the Division of Endocrinology, Diabetes and Metabolism at The University of Florida at Gainesville (2011-present). He is also a faculty and researcher at the Endocrinology, Diabetes and Metabolism Division at the Veterans Administration Medical Center at Gainesville, FL.
Kenneth Cusi, M.D., F.A.C.P., F.A.C.E.
Professor of Medicine
Chief, Division of Endocrinology, Diabetes and Metabolism at The University of Florida at Gainesville
Dr. Cusi is a Professor of Medicine and Chief of the Division of Endocrinology, Diabetes and Metabolism at The University of Florida at Gainesville (2011-present). He is also a faculty and researcher at the Endocrinology, Diabetes and Metabolism Division at the Veterans Administration Medical Center at Gainesville, FL.
He received his medical degree and did his internal medicine residency in Buenos Aires, Argentina and completed a fellowship in Endocrinology, Diabetes and Metabolism at Baylor College of Medicine, Houston, Texas. He worked in San Antonio, Texas (1992-2011) on the role of defects in insulin secretion and insulin resistance to the development of type 2 diabetes mellitus (T2DM), as well as on complications associated with T2DM, focusing on the underlying mechanisms of nonalcoholic fatty liver disease (NAFLD) in T2DM and its impact on dyslipidemia, diabetes control and cardiovascular disease.
Dr. Cusi published the first randomized, controlled trial on the role of pioglitazone for the treatment of NASH for patients with prediabetes or T2DM (Belfort et al, NEJM 2006). This was followed by a recent long-term study confirming the value of pioglitazone in this population (Cusi et al, Annals Intern Med 2016). Current work centers on discovering the mechanism(s) leading to NASH and searching for novel treatments.
Dr. Cusi has published over 200 original articles, reviews and book chapters in a broad spectrum of peer-reviewed journals. In addition to the New England Journal of Medicine and Annals of Internal Medicine, his work in T2DM and in NASH has been published in the Proceeding of the National Academy of Science; Journal of Clinical Investigation; Diabetes; Diabetes Care; Journal of Clinical Endocrinology and Metabolism; Diabetes, Obesity and Metabolism; American Journal of Physiology; Hepatology; Journal of Hepatology; Gastroenterology and others.
He is an associate editor and reviewer for many journals in the fields of endocrinology, metabolism, diabetes and liver disease.
He is a frequent invited lecturer to national and international meetings on the role of obesity and NAFLD in T2DM. He is a member of the National Institute of Health (NIH) Clinical and Integrative Diabetes and Obesity (CIDO) study section. He contributed to the panel of the 2012 and 2018 NASH guidelines of the American Association for the Study of Liver Diseases. In 2015, Dr. Cusi received two prestigious awards from the University of Florida, the Exemplary Teacher Award and the Clinical Research Award for outstanding achievement, research discovery, and productivity. In 2020, he received the American Association of Clinical Endocrinologists Jack Baskin, MD, Endocrine Teaching Award.
